NEW YORK (GenomeWeb News) – The Van Andel Institute and Spectrum Health have started a molecular technologies lab that will study genomics and proteomics for application in cancer, heart disease, mental illness, and other diseases, Spectrum Health said today.
Spectrum, a non-profit group that operates seven hospitals in Western Michigan, said the Center for Molecular Medicine, located in Grand Rapids, has $6 million in funding.
The CMM will use Van Andel’s infrastructure and employees along with Spectrum’s clinical lab and research resources.
Van Andel CEO and Chairman David Van Andel said Spectrum has “a large patient population which allows us to apply what we're learning directly into the clinical setting."
The CMM will house and use DNA and RNA extraction, DNA microarrays, multiplex protein detection, and gene-expression profiling.
Directing the CMM will be Dan Farkas, who Spectrum said has established three other hospital-based molecular diagnostics labs.